Version 2.80

Term Description

A 10-year breast cancer distant recurrence risk panel created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone. The panel includes terms for primary tumor size, lymph node status, distant recurrence risk score, and distance recurrence risk classification. The 10-year breast cancer distant recurrence risk score (also referred to as ROR Score or Risk of Recurrence Score) is a numerical score on a scale of 0 -100 that is calculated using a statistical model that includes: 1) the results from a 50-gene expression assay performed on formalin fixed paraffin embedded breast tumor tissue previously diagnosed as invasive carcinoma; 2) proliferation score; and 3) gross tumor size. The calculated score and information about lymph node status are used together to classify the patient into a risk category for distant breast cancer recurrence at 10 years.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
76546-1 Breast cancer 10-year risk of distant recurrence panel by Prosigna
Indent76397-9 Lymph node involvement
Indent21889-1 Size Tumor mm
Indent76544-6 Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna {score}
Indent76545-3 Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna

Fully-Specified Name

Component
Breast cancer 10Y risk of distant recurrence panel
Property
-
Time
Pt
System
^Patient
Scale
-
Method
Prosigna

Additional Names

Long Common Name
Breast cancer 10-year risk of distant recurrence panel by Prosigna
Short Name
Brst ca 10Y risk dist recur Pnl Prosigna
Display Name
Breast cancer 10-year risk of distant recurrence panel Prosigna
Consumer Name Alpha Get Info
Breast cancer 10-year risk of distant recurrence panel

Basic Attributes

Class
PANEL.MOLPATH
Type
Laboratory
First Released
Version 2.52
Last Updated
Version 2.52 (MIN)
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

Tag Language Translation
el-GR Greek (Greece) Πίνακας κινδύνου απομακρυσμένης υποτροπής του καρκίνου του μαστού σε 10 έτη:-:Pt:^Ασθενής:-:Prosigna
Synonyms: Καρκίνος Πίνακας κινδύνου απομακρυσμένης υποτροπής του καρκίνου του μαστού σε 10 έτη
es-ES Spanish (Spain) Panel genético para el riesgo a 10 años de recurrencia en el cancer de mama:Propiedades mixtas (sólo paneles):Punto temporal:^paciente:-:Sustrato 2,3-14C succinato
es-MX Spanish (Mexico) Panel de riesgo de recidiva a distancia de 10 años de cáncer de mama:-:Punto temporal:^ Paciente:-:Cuestionario de satisfacción con la atención de la psoriasis
fr-FR French (France) Risque de récidive du cancer du sein à 10 ans panel:-:Ponctuel:Patient:-:Test Prosigna
it-IT Italian (Italy) Tumore della mammella, rischio 10 anni di recidive tumorali, panel:-:Pt:^Paziente:-:Prosigna
Synonyms: Patologia molecolare paziente Punto nel tempo (episodio) Set di prescrizione patologia molecolare
zh-CN Chinese (China) 乳腺癌远处转移 10 年风险组套:-:时间点:^患者:-:Prosigna
Synonyms: Prosigna 法 乳腺癌远处转移（远程转移） 10 年风险（危险性、风险性、危险）组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;乳腺（乳房）肿瘤 分子病理学;分子病理学试验 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.分子病理学;分子病理学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;分子病理学医嘱组类;医嘱组类.分子病理学;实验室医嘱组类.分子病理学 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 癌 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=76546-1
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/76546-1